Without a doubt, COVID-19 has persisted for a lot longer than we had all anticipated. In Canadaalone, we have exceeded 300,000 total cases. Globally, we have surpassed an astonishing 59million cases, with over 1.4 million deaths. As we close in on one year since the pandemicbegan, the question on everyone’s mind is: “When are we getting a vaccine?”
In just a few months, the coronavirus pandemic has radically disrupted the world of medical conferences. What does this mean for healthcare providers, patient organizations, medical societies, pharmaceutical companies, and health marketing agencies? Let’s explore the significant underlying change drivers and possible long-term implications that COVID-19 has and will have on medical conferences in 2020 and beyond.
Doubtlessly, one of the defining phrases of the 2010s is “fake news.” We hear it being thrown around by politicians and celebrities alike, not to mention by social media users when they disagree with a news article or editorial. The Pharma industry is no stranger to fake news either.
As society begins planning to re-open businesses, protecting ourselves and each other from the coronavirus is still a paramount necessity. As we prepare to get back to a “new normal”, it’s important to remember that we’re armed with one of the oldest weapons in human history: SOAP.
With cancelled conferences, postponed ad schedules and on-hold in-person review meetings, marketing your brand and products during a global pandemic is tough. In this post, we explore some of the key ways Life Sciences and Pharmaceutical companies are pivoting their marketing efforts due to COVID-19 in order to meet the demands of this rapidly-changing climate.
Due to the COVID-19 outbreak, chances are your team has tested remote access through virtual private access (VPN) and adopted a working-from-home policy. And if you’re fortunate enough, teams already operating from a 100% remote office have not missed a beat in the wake of the pandemic.
The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive.
Great content is useful and usable. At Papercurve, we understand the lengths it takes to create useful and usable content for pharmaceutical and life sciences companies. From MLR review preparation to revisions, content must go through various stages of the review process before it becomes approved and published. That's why we created a checklist...
We all face it. Meeting the demands of regulatory standards is important but has the ability to significantly slow us down on our mission to deliver content. It can reduce time to market, conflicts with deadlines and schedules and ultimately drains out content creators and those involved in triaging stakeholder feedback.
We look to the team culture honing experts like Google and LinkedIn to uncover the best characteristics of a winning team. We’ll also look at the ways in which you can leverage these learnings as tools for your marketing team in 2020.
We’ve all been there before. Your manager just asked you for a file your predecessor stored in the previous year’s team folder. You try to find the file urgently, rushing through years and years of information only to realize it might take you less time to rewrite the file than try and guess where the file might’ve been stored in the first place. Why? Because organizing files through folders is only intuitive to the person storing them.
The Pharmaceutical Advertising Advisory Board, better known as PAAB, had their annual training and information sessions in Montreal and Toronto this week. Here are the top five highlights we gathered from the sessions.
Thanksgiving is steeped in history, whether it’s the beginnings of the Pilgrims’ harvest meal or that apple pie recipe that has been handed down through your family for generations. This week, we look at the origins of the first drug television ad.
We are making it easier to get your content into Papercuve. You can now upload Word and PowerPoint files without converting them to PDF first. This was our most requested feature and we’re excited to roll it out.
The origins of “Track Changes” in Microsoft Word go back as far as 1986. Over time this feature gained popularity as a way for people to collaborate on documents. But the cloud age has not been kind to Track Changes. Many collaborators working on a single document has caused chaos and a user experience nightmare. It’s time to give up on Track Changes.
Wherever your canna-business is located you have opportunities and challenges. New markets are opening up like the State of Illinois in January 2020 and new products are entering the market like edibles, beverages, and topicals in Canada starting Dec 17th. The challenges, however, can be daunting. So how do you help your business thrive in this kind of environment?
Most of us have used email to review and approve content. Everyone has email and knows how to use it, so how bad can it be? Pretty bad actually. Email approvals have several unseen and potentially costly drawbacks.
October 17 is more than just topicals, edibles and vaporizers. There are new regulations about document retention rules that impact licensed producers in Canada.
Last Friday was the inaugural Cannabis + Technology conference at the Steam Whistle Brewery in Toronto. As cannabis becomes legalized in more and more jurisdictions, technology is innovating the way that producers and governments maintain quality standards, store records, and sell products in a retail environment. Here are 2 key takeaways from Friday’s conference.
You have been through your fair share of internal content reviews as you work on getting things approved. There are patterns in how people approach these reviews. We came up with 5 types of approvers that you'll encounter – and how to deal with them.